Gorham's disease and diffuse lymphangiomatosis in children and adolescents

Pediatric Blood and Cancer

Volumn 56, Issue 4, 2011, Pages 667-670

  Venkatramani, Rajkumar ^a   Ma, Nina S ^a   Pitukcheewanont, Pisit ^a,b   Malogolowkin, Marcio H ^a,b   Mascarenhas, Leo ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bisphosphonates; Chylothorax; Interferon; Lymphangioma; Lymphatic malformation; Osteolysis; Vanishing bone disease

Indexed keywords

ALPHA2B INTERFERON; PAMIDRONIC ACID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPRESSION FRACTURE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; KYPHOSIS; LYMPHANGIOMA; LYMPHANGIOMATOSIS; MALE; MASSIVE OSTEOLYSIS; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SCHOOL CHILD; THYROIDITIS;

ADOLESCENT; CHILD; FEMALE; HUMANS; LYMPHANGIOMA; MALE; OSTEOLYSIS, ESSENTIAL; SOFT TISSUE NEOPLASMS;

EID: 79551638183     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22948     Document Type: Article

References (19)

1. Gorham LW, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 1955; 37-A: 985-1004.
2. Papadakis SA, Khaldi L, Babourda EC, et al. Vanishing bone disease: Review and case reports. Orthopedics 2008; 31: 278.
3. Takahashi A, Ogawa C, Kanazawa T, et al. Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: A severe case of Gorham-Stout syndrome. J Pediatr Surg 2005; 40: E47-E50.
4. Hagberg H, Lamberg K, Aström G. Alpha-2b interferon and oral clodronate for Gorham's disease. Lancet 1997; 350: 1822-1823.
5. Hammer F, Kenn W, Wesselmann U, et al. Gorham-Stout disease - stabilization during bisphosphonate treatment. J Bone Miner Res 2005; 20: 350-353.
6. Watkins RG, Reynolds RAK, McComb JG, et al. Lymphangiomatosis of the spine: Two cases requiring surgical intervention. Spine 2003; 28: E45-E50.
7. Fontanesi J. Radiation therapy in the treatment of Gorham disease. J Pediatr Hematol/Oncol 2003; 25: 816-817.
8. Barbagallo M, Incorpora G, Magro G, et al. Splenic lymphangiomatosis associated with skeletal involvement (Gorham's disease): A new case and review of literature. Minerva Pediatr 2009; 61: 231-236.
9. Dupond J, Bermont L, Runge M, et al. Plasma VEGF determination in disseminated lymphangiomatosis-Gorham-Stout syndrome: A marker of activity? A case report with a 5-year follow-up. Bone 2010; 46: 873-876.
10. Campbell J, Almond HG, Johnson R. Massive osteolysis of the humerus with spontaneous recovery. J Bone Joint Surg Br 1975; 57: 238-240.
11. Tie ML, Poland GA, Rosenow EC. Chylothorax in Gorham's syndrome. A common complication of a rare disease. Chest 1994; 105: 208-213.
12. Patrick JH. Massive osteolysis complicated by chylothorax successfully treated by pleurodesis. J Bone Joint Surg Br 1976; 58: 347-349.
13. Devlin RD, Bone HG, Roodman GD. Interleukin-6: A potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 1996; 81: 1893-1897.
14. Colucci S, Taraboletti G, Primo L, et al. Gorham-Stout syndrome: A monocyte-mediated cytokine propelled disease. J Bone Miner Res 2006; 21: 207-218.
15. Tammela T, Zarkada G, Wallgard E, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008; 454: 656-660.
16. Grunewald TGP, Damke L, Maschan M, et al. First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 2010; 21: 1733-1734.
17. Hagendoorn J, Padera TP, Yock TI, et al. Platelet-derived growth factor receptor-β in Gorham's disease. Nature clinical practice. Oncology 2006; 3: 693-697.
18. Franchi A, Bertoni F, Bacchini P, et al. CD105/endoglin expression in Gorham disease of bone. J Clin Pathol 2009; 62: 163-167.
19. Adams DHA. Rapamycin for the treatment of complicated vascular anomalies. Pediatr Blood Cancer 2010; 54: abstr 117.